NOX1 and hepatocellular carcinoma: Our results of overall safety of NOX1 inhibition on human HCC cells, the effect of NOX1 inhibition on pro-inflammatory macrophage polarization and the attenuated development of a pro-tumorigenic environment by NOX1 inhibition in experimental HCC, suggests this might be a very promising adjuvant therapeutic strategy in the treatment of advanced HCC.